Now showing items 1-1 of 1

    • Residual macrovascular risk in 2013: what have we learned? 

      Fruchart, Jean-Charles; Davignon, Jean; Hermans, Michel P; Al-Rubeaan, Khalid; Amarenco, Pierre; Assmann, Gerd; Barter, Philip; Betteridge, John; Bruckert, Eric; Cuevas, Ada; Farnier, Michel; Ferrannini, Ele; Fioretto, Paola; Genest, Jacques; Ginsberg, Henry N; Gotto, Antonio M; Hu, Dayi; Kadowaki, Takashi; Kodama, Tatsuhiko; Krempf, Michel; Matsuzawa, Yuji; Núñez-Cortés, Jesús Millán; Monfil, Carlos Calvo; Ogawa, Hisao; Plutzky, Jorge; Rader, Daniel J; Sadikot, Shaukat; Santos, Raul D; Shlyakhto, Evgeny; Sritara, Piyamitr; Sy, Rody; Tall, Alan; Tan, Chee Eng; Tokgözoğlu, Lale; Toth, Peter P; Valensi, Paul; Wanner, Christoph; Zambon, Alberto; Zhu, Junren; Zimmet, Paul (BioMed Central, 2014)
      Cardiovascular disease poses a major challenge for the 21st century, exacerbated by the pandemics of obesity, metabolic syndrome and type 2 diabetes. While best standards of care, including high-dose statins, can ameliorate ...